Natus Medical Incorporated (BABY):企業の財務・戦略的SWOT分析

◆英語タイトル:Natus Medical Incorporated (BABY) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C0191
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Natus Medical Incorporated (BABY) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Natus Medical Incorporated (Natus) is a provider of newborn and neurology healthcare products. It offers wide range of products for the screening, diagnosis, detection, treatment, monitoring and tracking of ailments in newborn. Natus offers products for diagnostic hearing assessment in children and adults, and for the diagnosis and treatment of balance and mobility disorders. It also offers products for screening, diagnosis, detection and treatment of neurological disorders including neurological dysfunction, epilepsy and sleep disorders. The company markets its products through direct sales force and distributors in several countries across the world. Natus is headquartered in Pleasanton, California, the US.

Natus Medical Incorporated Key Recent Developments

Jul 11,2018: Natus Medical Announces Leadership Changes
May 31,2018: Natus Medical Highlights Board’s Strengths and Management’s Track Record of Value Creation in Investor Presentation
Apr 25,2018: Natus Medical Announces First Quarter Financial Results
Feb 07,2018: Natus Medical Announces Fourth Quarter and Full Year 2017 Financial Results
Jan 08,2018: Natus Medical Announces 2018 Annual and First Quarter Financial Guidance

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Natus Medical Incorporated – Key Facts 6
Natus Medical Incorporated – Key Employees 7
Natus Medical Incorporated – Major Products and Services 8
Natus Medical Incorporated – History 12
Natus Medical Incorporated – Company Statement 14
Natus Medical Incorporated – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 – Company Analysis 17
Company Overview 17
Natus Medical Incorporated – Business Description 18
Product Category: Neurology 18
Overview 18
Performance 18
Product Category: Newborn Care 18
Overview 18
Performance 19
Product Category: Otometrics 19
Overview 19
Performance 19
Geographical Segment: Foreign Countries 19
Target Markets 19
Performance 19
Geographical Segment: United States 20
Performance 20
R&D Overview 20
Natus Medical Incorporated – Corporate Strategy 21
Natus Medical Incorporated – SWOT Analysis 22
SWOT Analysis – Overview 22
Natus Medical Incorporated – Strengths 22
Natus Medical Incorporated – Weaknesses 23
Natus Medical Incorporated – Opportunities 24
Natus Medical Incorporated – Threats 25
Natus Medical Incorporated – Key Competitors 26
Section 3 – Company Financial Ratios 27
Financial Ratios – Capital Market Ratios 27
Financial Ratios – Annual Ratios 28
Performance Chart 31
Financial Performance 31
Financial Ratios – Interim Ratios 32
Financial Ratios – Ratio Charts 33
Section 4 – Company’s Lifesciences Financial Deals and Alliances 34
Natus Medical Incorporated, Medical Equipment, Deals By Year, 2012 to YTD 2018 34
Natus Medical Incorporated, Medical Equipment, Deals By Type, 2012 to YTD 2018 35
Natus Medical Incorporated, Recent Deals Summary 36
Section 5 – Company’s Recent Developments 37
Jul 11, 2018: Natus Medical Announces Leadership Changes 37
Apr 25, 2018: Natus Medical Announces First Quarter Financial Results 39
Feb 07, 2018: Natus Medical Announces Fourth Quarter and Full Year 2017 Financial Results 40
Jan 08, 2018: Natus Medical Announces 2018 Annual and First Quarter Financial Guidance 42
Jan 05, 2018: Natus Appoints Leslie McDonnell as Vice President and General Manager of its Newborn Care Business Unit 43
Oct 25, 2017: Natus Medical Announces Third Quarter 2017 Financial Results 44
Jul 26, 2017: Natus Medical Announces Second Quarter 2017 Financial Results 46
Apr 26, 2017: Natus Medical Announces First Quarter 2017 Financial Results 48
Feb 01, 2017: Natus Medical Announces Fourth Quarter and Full Year 2016 Financial Results 49
Jan 09, 2017: Natus Medical Announces 2017 Annual And First Quarter Financial Guidance 51
Section 6 – Appendix 52
Methodology 52
Ratio Definitions 52
About GlobalData 56
Contact Us 56
Disclaimer 56

List of Tables
Natus Medical Incorporated, Key Facts 6
Natus Medical Incorporated, Key Employees 7
Natus Medical Incorporated, Major Products and Services 8
Natus Medical Incorporated, History 12
Natus Medical Incorporated, Other Locations 15
Natus Medical Incorporated, Subsidiaries 15
Natus Medical Incorporated, Key Competitors 26
Natus Medical Incorporated, Ratios based on current share price 27
Natus Medical Incorporated, Annual Ratios 28
Natus Medical Incorporated, Annual Ratios (Cont...1) 29
Natus Medical Incorporated, Annual Ratios (Cont...2) 30
Natus Medical Incorporated, Interim Ratios 32
Natus Medical Incorporated, Medical Equipment, Deals By Year, 2012 to YTD 2018 34
Natus Medical Incorporated, Medical Equipment, Deals By Type, 2012 to YTD 2018 35
Natus Medical Incorporated, Recent Deals Summary 36
Currency Codes 52
Capital Market Ratios 52
Equity Ratios 53
Profitability Ratios 53
Cost Ratios 54
Liquidity Ratios 54
Leverage Ratios 55
Efficiency Ratios 55

List of Figures
Natus Medical Incorporated, Performance Chart (2013 - 2017) 31
Natus Medical Incorporated, Ratio Charts 33
Natus Medical Incorporated, Medical Equipment, Deals By Year, 2012 to YTD 2018 34
Natus Medical Incorporated, Medical Equipment, Deals by Type, 2012 to YTD 2018 35

★海外企業調査レポート[Natus Medical Incorporated (BABY):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ARC Resources Ltd (ARX):企業の財務・戦略的SWOT分析
    ARC Resources Ltd (ARX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Endonovo Therapeutics Inc (ENDV):医療機器:M&Aディール及び事業提携情報
    Summary Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial stage development company that offers non-invasive medical devices and equipment. The company’s products include Electroceutical Therapy a FDA-Cleared for the palliative treatment of pain and post-surgical edema and CE Marked …
  • Arcus Biosciences Inc (RCUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Arcus Biosciences Inc (Arcus Biosciences) is a clinical stage bio-pharmaceutical company. The company develops and commercializes cancer immunotherapies. Its product pipeline includes AB928, which is in phase 1/1b trial; AB122 is being developed for cancer patients, is in Phase 1 trial; AB15 …
  • Cellectis SA (ALCLS):企業の財務・戦略的SWOT分析
    Summary Cellectis SA (Cellectis) operates as a clinical-stage biopharmaceutical company. It carries out research, develop and commercialize gene editing technology. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target a …
  • JB Hi-Fi Ltd (JBH):企業の財務・戦略的SWOT分析
    JB Hi-Fi Ltd (JBH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Immupharma Plc (IMM):製薬・医療:M&Aディール及び事業提携情報
    Summary ImmuPharma Plc (ImmuPharma) develops novel drugs for the treatment of serious medical conditions with unmet medical need. ImmuPharma develops drugs for the treatment of lupus, cancer, moderate to severe pain, highly resistant hospital-acquired infections such as methicillin-resistant staphyl …
  • Pioneer Corporation (6773):企業の財務・戦略的SWOT分析
    Pioneer Corporation (6773) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Ortivus AB (ORTI B):企業の財務・戦略的SWOT分析
    Summary Ortivus AB (Ortivus) is a supplier of mobile solutions for emergency medical care. The company develops and offers cardiology, and mobile monitoring and communication solutions. Its products include MobiMed Smart, CoroNet, excense heart record system and excense decision support healthcare s …
  • Scottish Enterprise:電力:M&Aディール及び事業提携情報
    Summary Scottish Enterprise is a business consulting firm that Supports firms to raise wage levels. The firm provides service such as attract investment, develop management team, do business outside Scotland, develop organization, develop new products and services, among others. It offers service su …
  • Promethera Biosciences SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Promethera Biosciences SA (Promethera) is a developer of cell therapy products for the treatment of liver diseases. The company provides products which are developed on its proprietary progenitor cell type. It offers products such as promethera hepastem and promethera hepascreen, among other …
  • Akorn Inc (AKRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Akorn Inc (Akorn) develops, manufactures, and commercializes generic and branded prescription pharmaceuticals and branded and over-the-counter consumer health products and animal health pharmaceuticals. The company offers its products in both sterile and non-sterile dosage forms including or …
  • CorMatrix Cardiovascular Inc:医療機器:M&Aディール及び事業提携情報
    Summary CorMatrix Cardiovascular Inc (CorMatrix) is a medical device company that offers biomaterial devices. The company’s products comprise interim bioscaffolds, cardiovascular devices, biomaterials, cardiovascular medical devices, extracellular matrix materials, cardiovascular surgery devices, cr …
  • CVS Health Corp (CVS):企業の財務・戦略的SWOT分析
    CVS Health Corp (CVS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • U.S. Energy Corp (USEG):企業の財務・戦略的SWOT分析
    Summary U.S. Energy Corp (US Energy) is an oil and gas company that offers exploration, development and production of oil and natural gas properties. The company provides maintenance of mineral properties. It operates its oil and gas prospects located in the Williston Basin of North Dakota, the Eagl …
  • Epicor Software Corp:企業の戦略的SWOT分析
    Epicor Software Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • CapitalSource:企業の戦略・SWOT・財務情報
    CapitalSource - Strategy, SWOT and Corporate Finance Report Summary CapitalSource - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Streamwide SA (ALSTW):企業の財務・戦略的SWOT分析
    Streamwide SA (ALSTW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • PATRIZIA Immobilien AG:企業のM&A・事業提携・投資動向
    PATRIZIA Immobilien AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PATRIZIA Immobilien AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • CTI BioPharma Corp (CTIC)-製薬・医療分野:企業M&A・提携分析
    Summary CTI BioPharma Corp (CTI BioPharma) is a biopharmaceutical company, which acquires, develops, and commercializes targeted therapies for a range of blood-related cancers. The company’s lead product, Pixuvri (pixantrone) is an aza-anthracenedione used for the treatment of multiply relapsed or r …
  • Evogene Ltd (EVGN):企業の財務・戦略的SWOT分析
    Summary Evogene Ltd (Evogene), a subsidiary of Compugen Ltd, is a biotechnology company that offers plant genomic services. The company offers solutions for crop production improvement through breeding. It develops biotechnology and advanced breeding improved traits for crops that feed the world, in …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆